Soultan Al-Halifa
Director, Research & Development, Biopharmaceutical Chemistry Feldan Therapeutics
Seminars
Thursday 30th April 2026
Revolutionizing Intracellular Delivery with an Advanced Peptide-Based Platform for Clinical Success
11:30 am
- Pioneering endosomal escape through rationally designed peptide shuttles, enabling efficient delivery of small molecules, proteins, enzymes and oligonucleotides across diverse cell types
- Delivering functional biomolecules in different animal models
- Demonstrating clinical potential of the Feldan technology through in vivo data and progression to first-in-human trial for basal cell carcinoma
NEW COMPANY
